Jimmy Lin

Natera has appointed Jimmy Lin as chief scientific officer for oncology. Lin most recently led the clinical genomics program at the National Cancer Institute at the National Institutes of Health. Previously, he led the computational analysis of the first ever exome sequencing studies in cancer at Johns Hopkins. Additionally, Lin is the founder and president of the Rare Genomics Institute.